Literature DB >> 1538375

Tryptophan induced eosinophilia-myalgia syndrome: clinical and microscopic findings.

R W Groves1, K J Simpson, S Koblar, C Pitzalis, R J Hay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1538375      PMCID： PMC1294899          DOI： 10.1177/014107689208500221

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

Review 1.  Cutaneous mucinosis in a patient with eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.

Authors:  D B Dubin; T H Kwan; M O Morse; D C Case
Journal:  Arch Dermatol       Date:  1990-11

2.  Dermal mucinosis in the eosinophilia-myalgia syndrome.

Authors:  K L Farmer; A A Hebert; R P Rapini; R E Jordan
Journal:  Arch Dermatol       Date:  1990-11

3.  Smooth muscle differentiation in scleroderma fibroblastic cells.

Authors:  A P Sappino; I Masouyé; J H Saurat; G Gabbiani
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

4.  Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease.

Authors:  L D Kaufman; R J Seidman; M E Phillips; B L Gruber
Journal:  J Am Acad Dermatol       Date:  1990-12       Impact factor: 11.527

5.  The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology.

Authors:  R W Martin; J Duffy; A G Engel; J T Lie; C A Bowles; T P Moyer; G J Gleich
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.